An ongoing clinical trial called "BREAKWATER" is showing great promise for metastatic colon cancer patients with a particular ...

Here is a recap of every FDA approval announced by the regulatory agency in the month of May, spanning various cancer types.

Recent advances have resulted in highly effective "tissue-agnostic" drugs that treat cancers based on their molecular markers ...

The FDA has approved darolutamide without chemotherapy for treatment of metastatic hormone-sensitive prostate cancer.The FDA ...

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs – used ...

Discover the major highlights from ASCO 2025, according to researchers and drug developers who attended the convention.

An "AI scientist," working in collaboration with human scientists, has found that combinations of cheap and safe drugs—used ...

Innovent Biologics updates results of IBI343 from phase 1 clinical study in patients with advanced pancreatic cancer: San Francisco Wednesday, June 4, 2025, 14:00 Hrs [IST] Innove ...

Market analysts believe the real effects of these tax changes on the capital market will become clearer over time ...

Kona Community Hospital’s long-awaited pharmacy expansion is finished after breaking groun d on the project almost two years ...

Actinium-225 and some other radioactive elements that emit alpha rays can be transformed into cancer-fighting missiles if they are attached to ...

Biontech SE and Bristol Myers Squibb Co. are teaming up to develop Biontech’s bispecific antibody targeting PD-L1 and VEGF-A, BNT-327, in a deal possibly worth over $11 billion. The companies will ...